close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

47.65 +1.89 (+4.13%)
Streaming Delayed Price Updated: 11:52 AM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 375,764
Open 46.28
Bid (Size) 47.61 (200)
Ask (Size) 47.69 (200)
Prev. Close 45.76
Today's Range 46.28 - 47.72
52wk Range 25.36 - 46.34
Shares Outstanding 45,882,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth ↗
AtriCure (NASDAQ:ATRC) said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product... 
Via MarketBeat
News headline image
Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors ↗
The sale came at $38.42 per share, slightly below the day's market close, as AtriCure maintains its $2.0 billion market cap in the medical device sector. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+21.3%
+21.3%
1 Month
+37.0%
+37.0%
3 Month
+65.5%
+65.5%
6 Month
+44.5%
+44.5%
1 Year
+33.8%
+33.8%

More News

Read More
News headline image
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It ↗
Via The Motley Fool
Topics Regulatory Compliance
AtriCure (NASDAQ:ATRC) Profitability Surge Drives After-Hours Rally Despite Inline Revenue ↗
Via Chartmill
AtriCure (NASDAQ:ATRC) Q1 Results Beat Estimates as Company Reaches Key Profitability Milestone ↗
Via Chartmill
AtriCure Inc (NASDAQ:ATRC) Stock Surges on Q4 2025 Earnings Beat and Profitability Milestone ↗
Via Chartmill
Topics Earnings
News headline image
AtriCure to Participate at Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
AtriCure Reports Second Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Second Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook ↗
Via MarketBeat
News headline image
AtriCure (ATRC) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
AtriCure Reports First Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? ↗
Via The Motley Fool
Topics Derivatives Regulatory Compliance
News headline image
AtriCure to Participate in the Citizens Life Sciences Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure (ATRC) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
From AtriCure, Inc.
Via Business Wire

Frequently Asked Questions

Is AtriCure, Inc. - Common Stock publicly traded?
Yes, AtriCure, Inc. - Common Stock is publicly traded.
What exchange does AtriCure, Inc. - Common Stock trade on?
AtriCure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtriCure, Inc. - Common Stock?
The ticker symbol for AtriCure, Inc. - Common Stock is ATRC on the Nasdaq Stock Market
What is the current price of AtriCure, Inc. - Common Stock?
The current price of AtriCure, Inc. - Common Stock is 47.65
When was AtriCure, Inc. - Common Stock last traded?
The last trade of AtriCure, Inc. - Common Stock was at 08/19/26 11:52 AM ET
What is the market capitalization of AtriCure, Inc. - Common Stock?
The market capitalization of AtriCure, Inc. - Common Stock is 2.19B
How many shares of AtriCure, Inc. - Common Stock are outstanding?
AtriCure, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.